Avicenna Biosciences
Avicenna Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 2 tracked investors.
About Avicenna Biosciences
Avicenna Biosciences is a startup founded in 2022 based in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Avicenna Biosciences uses a machine-learning-driven medical chemistry platform to screen and optimize candidate drug molecules, accelerating drug discovery and reducing toxicity risks. The company has developed a new Rho kinase (ROCK) inhibitor aimed at neurodegenerative disease and is conducting IND-enabling studies.
Explore Avicenna Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.